Abstract
Modified vaccinia Ankara (MVA) vector-based vaccines are attractive because of their excellent safety and ability to induce long-lived humoral and cellular immunity in humans. Routhu et al. show that an MVA-based COVID-19 vaccine encoding prefusion-stabilized spike (MVA/S) induces strong neutralizing antibody and CD8+ T cell responses and protects macaques from SARS-CoV2 infection, immunopathology, and infection-induced B cell abnormalities in the lungs.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 542-556.e9 |
| Journal | Immunity |
| Volume | 54 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 9 2021 |
Keywords
- CD8 T cells
- COVID-19
- Modified Vaccinia Ankara
- Neutralizing antibody
- Protection
- Rhesus macaques
- SARS-CoV-2
- Spike
- Vaccine
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS